Plenty of initiating trials and IND submissions there. Not to mention half these were expected last year. I'm curious on NSCLC HOT data, but that's about it at this point.
The market is done with Advaxis until they can show partnerships with real cash to run all these trials... instead of diluting and destroying shareholders every chance they get.
Where's the money!? 20 years of operation and here they are... barely a P1.
Thank you kind sir for your diligence. Glad to have you help fight the good fight. It`s been nothing but moaning and crying that it`s over for this company for more then 2 years by the mobsquad. It`s time to talk about the potential for the company,because the stocks so way oversold it`s ridiculous.
Thanks,great post. Now ADXS just needs to deliver some scientific results, which I believe they can. That is quite a list. I think HOT has great merit.
If Advaxis had anything to showcase, ESMO 2019 would have been the perfect forum to do so (9/27-10/1). They used to go there and present the data, last time 2 years ago. Nothing this time. There will not any other major conference until April ‘20 (AACR and then ASCO). That’s too far out. No catalyst until then as it appears.
News 
Market Data 
Discover 
AI
